Inmune Bio Files 8-K Report
Ticker: INMB · Form: 8-K · Filed: May 14, 2025 · CIK: 1711754
| Field | Detail |
|---|---|
| Company | Inmune Bio, Inc. (INMB) |
| Form Type | 8-K |
| Filed Date | May 14, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, corporate-update
Related Tickers: INMB
TL;DR
INMB filed an 8-K, likely with financial updates. Keep an eye out.
AI Summary
On May 14, 2025, Inmune Bio, Inc. filed an 8-K report. The filing primarily concerns "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's financial status and business operations. No specific new material events or financial figures were detailed in the provided excerpt.
Why It Matters
This filing signals to investors that Inmune Bio, Inc. is providing updated information to the SEC, which could include material business developments or financial disclosures.
Risk Assessment
Risk Level: low — The filing is a routine 8-K report, and the provided excerpt does not contain information indicating significant new risks or negative developments.
Key Players & Entities
- Inmune Bio, Inc. (company) — Registrant
- May 14, 2025 (date) — Date of earliest event reported
- Nevada (jurisdiction) — State of incorporation
- 47-5205835 (identifier) — IRS Employer Identification No.
- 225 NE Mizner Blvd. , Suite 640 , Boca Raton , Florida 33432 (address) — Address of Principal Executive Offices
- 858-964-3720 (phone_number) — Registrant's Telephone Number
FAQ
What is the primary purpose of this 8-K filing for Inmune Bio, Inc.?
The filing is for "Other Events" and "Financial Statements and Exhibits," indicating updates or disclosures related to the company's business operations and financial status.
On what date was this 8-K report filed or effective?
The report was filed as of May 14, 2025, and the date of the earliest event reported is also May 14, 2025.
In which U.S. state is Inmune Bio, Inc. incorporated?
Inmune Bio, Inc. is incorporated in Nevada.
What is the principal executive office address for Inmune Bio, Inc.?
The principal executive offices are located at 225 NE Mizner Blvd., Suite 640, Boca Raton, Florida 33432.
Does the filing excerpt mention any specific new product developments or clinical trial results?
No, the provided excerpt of the 8-K filing does not mention any specific new product developments or clinical trial results.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Inmune Bio, Inc. (INMB).